Modulation of focal adhesion constituents and their down-stream events by EGF: On the cross-talk of integrins and growth factor receptors  by Eberwein, Philipp et al.
Biochimica et Biophysica Acta 1853 (2015) 2183–2198
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrModulation of focal adhesion constituents and their down-stream events
by EGF: On the cross-talk of integrins and growth factor receptorsPhilipp Eberwein a, Dougal Laird b, Simon Schulz b, Thomas Reinhard a, Thorsten Steinberg b,⁎, Pascal Tomakidi b
a University Eye Hospital Freiburg, Department for Ophthalmology, Germany
b University Medical Center Freiburg, Department of Oral Biotechnology, Germany⁎ Corresponding author.
http://dx.doi.org/10.1016/j.bbamcr.2015.06.004
0167-4889/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 2 December 2014
Received in revised form 27 May 2015
Accepted 12 June 2015








MechanotransductionWithin the concept of integrin growth factor receptor (GFR) cross-talk, little is known about the effects of GFRs on
focal adhesions (FAs). Therefore, we tested the hypothesis whether EGF can modulate constituents of FAs and
subsequent down-stream events. To this end, EGF-treated keratinocytes were subjected to combined ﬂuores-
cence imaging and western blotting, to quantify expression and/or activation of molecules, involved in integrin
GFR cross-talk, and receptor proximal and distal signaling events. Generally, EGF response revealed an ampliﬁed
redistribution or activation of molecules under study, which will be explained in detail from the plasma mem-
brane to the cell interior. In addition to signiﬁcant activation of EGF receptor (EGFR) at tyrosine Tyr845, a remark-
able redistribution was detectable for the focal adhesion constituents, integrin ß1 and ß3, and zyxin. Increased
activation also applied to focal adhesion kinase (FAK) by phosphorylation at Tyr397, Tyr576, and Src at Tyr418,
while total FAK remained unchanged. Risen activitywas seen aswell for the analyzed distal down-streamevents,
p190RhoGAP andMAP kinases p42/44. Intriguingly, Src-speciﬁc inhibitor Herbimycin A abrogated the entire EGF
response except FAK Tyr397 phosphorylation, independent of EGF presence. Mechanistically, our results show
that EGF modulates adhesion in a dual fashion, by ﬁrstly redistributing focal adhesion constituents to adhesion
sites, but also by amplifying levels of activated RhoA antagonist p190RhoGAP, important for cellmotility. Further,
the ﬁndings suggest that the observed EGF response underlies an EGFR integrin cross-talk under recruitment of
receptor proximal FAK and Src, and MAP kinase and p190RhoGAP as receptor distal events.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Integrins as transmembrane heterodimers are indispensable for cell
adhesion to an extracellular environment, naturally represented by any
type of extracellular matrix (ECM) [1]. Integrins can either be part of
focal complexes located in the posterior region of a lamellipodia or in
focal adhesions (FAs) [2], which are formed upon the suspension of ad-
vancement or retraction of the cell's leading edge. Here, ß3 integrin par-
ticularly in conjunction with zyxin has been reported during the
transition from focal complexes to deﬁnitive FAs, also called mature or
late stage FAs ([3–5], for review see [6,7]).With respect to FAs, integrins
involved in their formation belong to the ß3 and/or ß1 families [1], the
latter also constituting ﬁbrillar adhesions in 2D cell cultures [8].
Integrins in conjunction with other intracellular components of
FAs form the adhesome, intracellularly connected with the actin
cytoskeleton. This outside-in/inside-out interconnection makes FA
switchboards within the ﬁne-tuned mutual interplay between the bio-
mechanical properties of the extracellular environment, i.e. stiffness
and adhesion ligand spacing etc., and the cell-innate cytoskeletalbiomechanics [9]. By adjustment of their cytoskeletal organization,
cells can adapt to environmental cues via FAs, while environmental
sensing includes both, integrin-mediated mechanobiological responses
induced by mechanosensing and mechanotransduction, but also
growth factor receptor-triggered signaling.
Classically, growth factor receptor-induced signaling requires
binding of one or a range of speciﬁc growth factors to the receptor,
e.g. EGF receptor (epidermal growth factor receptor/EGFR). With
regard to EGFR, ligand binding leads to its dimerization and
autophosphorylation-initiated activation, followed by endocytotic in-
ternalization and optional recycling or progressive lysosomal degrada-
tion, preceding receptor ubiquitination [10,11]. On the receptor
proximal site, EGFR stimulated activation of PLC (phospholipase
C) is required for induction of cell motility [12], while EGFR promoted
MAP-kinase signaling via ERK1/2 [13] can inﬂuence both proliferation
and motility [10,14]. Classical growth factor receptor activation occurs
upon ligand binding, in case of EGFR soluble EGF, but alternative ways
of EGFR activation have been described, which are mainly based
on interactions between growth factor receptors and adhesion-
facilitating integrins (for review see [15]). Consequently, these physical
interactions between integrins and growth factor receptors, as demon-
strated by co-localization and co-precipitation experiments for EGFR
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an adhesion-dependent, ligand-independent activation of growth
factor receptors. For ß1 integrin-coupled EGFR activation, adhesion-
dependent Src activation seems to be crucial [17], and active Src, unlike
soluble EGF, phosphorylates EGFR at tyrosine (Y) 845 and not at one of
the common sites Y1148 [18,19]. Thus, active Src kinase seems to play a
critical role in EGFR transactivation ([5,17] for review see [20]). In this
context it should be noted that collaborative synergy between ligand-
occupied integrins and ligands of growth factor receptors such as EGF,
PDGF-BB (platelet-derived growth factor) and basic FGF (ﬁbroblast
growth factor) has been demonstrated to result in a marked transient
increase in MAP-kinase/ERK activation [21]. Experimentally, the physi-
cal link of this collaborative synergy has been shown to be provided
by the non-receptor protein tyrosine kinase focal adhesion kinase FAK.
As exempliﬁed for the PDGF-ß receptor, FAK forms a complex with
the activated receptor upon ligand binding, with FAK positively contrib-
uting to PDGF-BB-stimulated MAP-kinase/ERK2 activity [22]. Detailed
analysis on FAK plus as well as minus and FAK-reconstituted cells
revealed that Tyr397-phosphorylated FAK, now accessible for Src-
binding, acts as an integrin-receptor-proximal bridging protein, which
associates with activated growth factor receptors via its N-terminal do-
main, thereby promoting PDGF and/or EGF-triggered cell migration
[23]. Together with integration of FAK as a bridge between integrin
and growth factor receptor (GFR), which is called collaborative activa-
tion, a non-collaborative mode of action for GFR activation has also
been described, involving p130cas instead of FAK ([24,25] for review
see [26]). In addition to its contribution to MAP-kinase activation as
one receptor-distal event, the cross-talk between growth factor recep-
tors and integrin receptors for further distal events includes impact on
molecules important for lamellipodia formation during cell motility.
This has been obtained from studies on the ß3 integrin/EGFR pathway,
important for activation of p190RhoGAP, which antagonizes the action
of the actin cytoskeleton-organizing small GTPase RhoA, thereby con-
tributing to motility events [27].
In the present study, we consistently detect redistribution of FA con-
stituents to adhesion sites in conjunction with increased transactivation
of EGFR as well as FA-integrin-proximal mechanotransducing elements
FAK and Src, together with p42/44 MAP-kinases and p190RhoGAP as re-
ceptor distal events by EGF administration.With respect tomodulation of
adhesion, our results suggest a dual effect of EGF, which on the one hand
is substantiated by clear changes of localized levels of constituents ofma-
ture FAs to adhesion sites, thereby indicating their redistribution, and on
the other hand by triggering events important for cell motility. These re-
sults provide a better understanding of the integrin growth factor recep-
tor cross-talk and its underlying mechanisms, which contribute to the
regulation of cell behavioral features such as adhesion and/or motility.
2. Materials and methods
2.1. Cell lines and maintenance
HPV16 E6/E7-immortalized corneal keratinocytes [28]were cultivat-
ed in Bio-One Cellstar cultivation ﬂasks (Greiner, Frickenhausen,
Germany) in Keratinocyte GrowthMedium2 (KGM) (Promocell, Heidel-
berg, Germany) with supplied supplements: bovine pituitary extract —
0.004 ml/ml, epidermal growth factor (EGF) — 0.125 ng/ml, insulin —
5 μg/ml, hydrocortisone — 0.33 μg/ml, epinephrine — 0.39 μg/ml,
transferin — 10 μg/ml, CaCl2 — 0.06 mM. Cultivation was carried out in
a Hera Cell 150 cultivation chamber (Thermo Electron Corporation,
Langenselbold, Germany) at 37 °C with 5% CO2. Cells were passaged at
approximately 90% conﬂuence and retained between passages 60–80.
2.2. Immunocytochemical staining
Round glass coverslips (22 mm diameter x 0.13–0.16 thicknesses,
Langenbrinck, Emmendingen, Germany) were treated with 10% w/vKOH in 100% ethanol for 30 min, washed 10 times in distilled water,
then stored in 100% ethanol until use. Immediately before use, said
coverslips were washed 3 times in PBS and placed into 6 well plates
(Bio-One Greiner, Frickenhausen, Germany). Corneal keratinocytes
(immortalized HPV 16 1617 L, passages 60–80) were seeded out onto
the coverslips at 7.5 x 104 cells/well (78 cells/mm2) in 3 ml medium
KGM prepared with supplied supplements at standard concentrations
as listed above.
Cells were cultivated for 72 h at 37 °C, 5% CO2, thenmediumwas as-
pirated and replaced with starving medium consisting of either KGM
without supplements, or KGMwithout supplements but with the addi-
tion of Herbimycin A (1 μg ml), (Santa Cruz Biotechnologie, Heidelberg,
Germany). Cells were cultivated for a further 24 h at 37 °C, 5% CO2, after
which time the experimental proper was commenced. Medium was
aspirated and replaced by one of the following treatment mediums
prepared as follows: a) starving medium, b) starving medium contain-
ing 1.56 ng / ml epidermal growth factor (Recombinant Human
Epidermal Growth Factor (E. coli-derived) (EGF), PromoKine, Heidel-
berg, Germany), c) starving medium with Herbimycin (1 μg/ml)
and 1.56 ng/ml EGF and d) starving medium with Herbimycin only
(1 μg/ml). Cultivation was continued at 37 °C, 5% CO2 and samples
collected for immunochemical histological staining at 30 min after
application.
Staining proceeded by ﬁrst aspirating medium and immediately
thereafter washing quickly and gently once with PBS. Samples were
ﬁxed with 4% formaldehyde for 10 min, washed 3 times for 5 min
with PBS, blocked and permeabilized with 1% BSA (Sigma, St. Louis,
USA)+ 0.1% Triton X-100 (Sigma, St. Louis, USA) for 30min then treat-
ed 1 h at room temperature with the primary antibody diluted to 1:200
in 1% BSA in PBS. Primary antibodies used and the companies from
which they were sourced are as follows: anti-Src (phospho Tyr418)
antibody (Abcam, Cambridge, UK); anti phospho-p44/42 (Erk1/2)
(T202/Y204) Rabbit mAb antibody, (New England BioLabs GmbH,
Frankfurt am Main, Germany), anti-p190RhoGAP [p Tyr1105] antibody
(Novus Biologicals, Littleton, USA); anti EGF-R (PhosphoY845) (Santa
Cruz Biotechnologie, Heidelberg, Germany); anti-Zyxin antibody
(Abcam, Cambridge, UK); anti-Integrin beta 3 [BV4] antibody (Abcam,
Cambridge, UK); anti EEA 1 (early endosome marker, Abcam, Cam-
bridge, UK) and anti-Integrin beta 1 [12G10] antibody (Abcam, Cam-
bridge, UK).
Following exposure to the primary antibody, samples were washed
3 times for 5 min with PBS and treated for 40min at room temperature
with the appropriate secondary antibody (either Alexa Fluor®
594 F(ab')2 Fragment of Goat Anti-Mouse IgG (H + L) or Alexa Fluor®
594 Goat Anti-Rabbit IgG (H + L) Antibody, LifeTechnologies, Darm-
stadt, Germany) diluted to 1 : 200 and mixed with phalloidin (Alexa
Fluor® 488 Phalloidin, LifeTechnologies, Darmstadt, Germany) diluted
to 1:40 in 1% BSA in PBS. Thereafter, samples were washed twice for
5 min with PBS, once more for 5 min with water and mounted on a
glass slide with RotiMount mounting medium containing DAPI
(Roti®-Mount FluorCare DAPI, Carl Roth, Karlsruhe, Germany). Samples
were stored overnight at 4 °C allowing the mounting medium to set,
sealed with nail polish and examined using a Keyence BZ-9000 ﬂuores-
cence microscope (KEYENCE GmbH, Neu-Isenburg, Germany).2.3. Western blotting
Corneal keratinocytes (immortalized HPV 16 1617 L, passages 60–
80) were seeded out into 9.6 cm diameter cell cultivation Petri dishes
(Greiner, Frickenhausen, Germany) at 5.0 x 105 cells/Petri dish in
10 ml in KGM with standard supplement concentrations (see above).
Cells were cultivated for 72 h (37 °C, 5% CO2), after which timemedium
was aspirated and replaced with starving medium (supplement free
KGM). Herbimycin was added to starving medium at 1 μg/ml for those
samples exposed to Herbimycin, while supplement free KGM only
2185P. Eberwein et al. / Biochimica et Biophysica Acta 1853 (2015) 2183–2198was added to samples to be treated later solely with EGF during the ex-
perimental phase.
Cells were incubated for a further 24 h before mediumwas aspirated
and replaced by 8 ml treatment medium containing: a) Herbimycin
(1 μg/ml), 1.56 ng/ml EGF, b) Herbimycin (1 μg/ml) and c) EGF
(1.56 ng/ml). Cells were incubated further at 37 °C (5% CO2) and samples
for each treatment removed at time points 30min. Mediumwas aspirat-
ed from each sample, cells washed oncewith 1 x PBS, petri dishes placed
on ice then cells lysed with 400 μl Complete Lysis-M Buffer (Roche,
Mannheim, Germany) with PhosSTOP (Roche, Mannheim, Germany)
phosphatase inhibitor cocktail containing protease and phosphorylase
inhibitors. Protein concentration was established with aid of the Pierce
660 nm Protein Assay (Thermo Scientiﬁc, Rockford, USA) performed ac-
cording to themanufacturer's instructions. Protein sampleswere divided
into 50 μl aliquots and frozen at−80 °C until required for western blot.
Western blot was performed using Criterion™ TGX Stain-Free™
Precase Gels (Bio-Rad, München, Germany). 20 μg protein was mixed
with Laemmli buffer (2x Laemmli Sample Buffer, Bio-Rad, München,
Germany) and loaded into each western blot pocket according to
manufacturer's instructions. Gels were run at 80 V and 0.09 A, 18 W
for approximately 2 h and subsequently blotted onto polyvinylidene
ﬂuoride (PVDF) membrane (Trans-Blot® Turbo™Midi PVDF, Bio-Rad,
München, Germany)
Blots were blocked with 5% BSA in TTBS for 2 h before the addition
of primary antibodies diluted to 1:1000 in 1% BSA / TTBS. Blots were
incubated for 24 h at 4 °C with gentle shaking, washed 3 x TTBS, then
incubated with the secondary antibody (either Immun-Blot Goat Anti-
Rabbit IgG (H + L)-AP, Cat. No. 170–6460, or Immun-Blot Goat Anti-
Mouse IgG (H + L)-AP, Cat. No. 170–6461, Bio-Rad, München,
Germany) prepared as per manufacturer's instructions and shaken
gently for 40min. Thereafter, gelswerewashed 3 x TTBS and 2 x TBS be-
fore 10 ml development solution was added. The membrane was
allowed to develop while being gently shaken for 10–20 min until
bands were clearly visible, while the background intensity remained
negligible.
2.4. Densitometric analysis of western blot
Developed western blots were either scanned or photographed
digitally and ﬁles thereof imported into BioDocAnalyze (Göttingen,
Germany) gel software for analysis. With aid of this software gel lanes
were allocated and peaks selected corresponding to protein bands. Re-
gions above a speciﬁc common densitometric threshold were selected
yielding volume (area multiplied by optical intensity). Three technical
replicates were made of the densitometric measurements for each
band on a speciﬁc gel. The means of technical replicates for all bands
for a speciﬁc blotting experiment were averaged to give a single value
against which all bands were normalized for separate blotting experi-
ments (biological replicates). This provided the means to meaningfully
compare the results of each blotting experiment (n = 3). Means for
each band were entered into the statistics software GraphPad, Prism
and the statistical difference between cells treated with EGF only and
other treatments investigatedwith a non-paired Student's t-test. Signif-
icances thereof are presented in diagrams according to the following
convention: p b 0.05, signiﬁcant (*).
2.5. Semi-quantitative ﬂuorescence imaging (SQFI)
For a speciﬁc antibody, ﬂuorescence photographs were acquired
with a Keyence BZ-9000 ﬂuorescence microscope under identical illu-
mination and exposure time conditions, in order to allow meaningful
comparison in ﬂuorescence intensity between treatments. Exposure
time for phalloidin and DAPI were varied if required to optimize
image quality. The channel corresponding to each speciﬁc anti-body (al-
ways red channel) was imported into the image analysis software
ImageJ for analysis. In Figs. 1–10 this channel was converted topseudo-color images so called heat maps, showing single pixel values
from 0–255, which in ascending order represent ﬂuorescence intensity
and thus the frequency of occurrence of an antigen in colors, ranging
from black (pixel value = 0) over blue, green (pixel value = 128),
and yellow to white (pixel value = 255), with 255 referring to 100%
ﬂuorescence signal intensity. For analysis, images were converted to
grayscale and each individual cell was circled as a Region of Interest
(ROI). The mean gray value for each cell was calculated and corrected
for background, and then the mean of each cell was averaged to yield
a single intensity value for one photograph. This methodology has
been used by us previously [29] and yielded results indistinguishable
from those calculated when using a comparable method described by
Burgess et al. [30]. Several slides for each antibody and treatment
(n N 3) were likewise examined and collated in the statistical software
GraphPad (Prism), where an unpaired Student's t-test was performed
to establish statistical signiﬁcance between EGF treated samples and
other treatments. Signiﬁcance thereof is presented in diagrams accord-
ing to the system as described in 2.4.
3. Results
3.1. Soluble EGF triggers EGF-receptor (EGF-R) activation at Src-speciﬁc
sites
Tomaintain both the transmembrane receptor tyrosine kinase EGFR
and integrin receptor system in a steady state level of activation, we
employed glass-adherent immortalized corneal keratinocytes and solu-
ble EGF as genuine EGFR-ligand. By using this modus operandi, we ana-
lyzed the EGF response by ﬁrstly focusing on the EGFR itself. After
administration of soluble EGF, ligand-activated EGFR is usually
autophosphorylated at multiple tyrosine (Tyr) residues, which among
others include Tyr992, Tyr1068, Tyr1086, Tyr1148, and Tyr1173 ([31]
for review see [20]). While Tyr-residue-autophosphorylation provides
docking sites for EGFR-interacting signaling molecules harboring a
phosphotyrosine binding sequence, serine (Ser) residue phosphoryla-
tion, for example Ser1142 [31], appears to be of regulatory importance,
due to its role in receptor dimerization, catalytic activity, and turn-over
[32]. In addition to these common activation sites, another phosphory-
lation site, represented by Tyr845 reﬂects the site through which EGFR
has originally been found to be transphosphorylated by the cytoplasmic
non-receptor tyrosine kinase Src ([33–35] for review see [20]). This
transphosphorylation is facilitated through Src–EGFR-complex forma-
tion and thus physical interaction of both molecules [36]. Since in our
study, wemainly focus on Src as a putative proximal EGFR-/integrin-re-
ceptor cross-talk target in corneal keratinocytes, we scrutinized EGFR
phosphorylation at the Src-speciﬁc site Tyr845.
To properly evaluate the immunolocalization and the frequency of
occurrence of Tyr845 EGFR transactivation, we carried out indirect im-
munoﬂuorescence imaging. By combining ﬂuorescence imaging with
calculation of ﬂuorescence intensity through software-based detection
of antigen-speciﬁc ﬂuorescent pixel measurement, we were able to
semi-quantify the frequency of occurrence of an antigen, i.e. target bio-
marker and thereby its level of localization and/or its activation stage, as
it was the casewith EGFR. This approach, on the following termed semi-
quantitative ﬂuorescence imaging (SQFI), has been successfully used in
our former studies to quantitatively estimate the frequency of occur-
rence of various tissue cell-speciﬁc biomolecules [28,29,37,38]. More-
over, to veritably show that increase in speciﬁc antigen ﬂuorescence
coincides with increased frequency of occurrence of an antigen under
study, inlays in Figs. 1–10 show heat maps in which ﬂuorescence pixel
intensity was converted into pseudo-colors, the latter indicating
strength of expression in a color range from black = lack of frequency
of occurrence to white = strong frequency of occurrence. As shown in
Fig. 1, EGF induced a signiﬁcant increase in EGFR phosphorylation at
Tyr845 (Fig. 1A) when compared with EGF-deprived control cultures
(Fig. 1B). With respect to the quality of the red Tyr845 signal,
Fig. 1. Phospho-EGFR (Tyr845) staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A.With 30minute expo-
sure to 1.56 ng/ml EGF. B.Without EGF stimulation. C.WithHerbimycinA (Herb) treatment andwith EGF stimulation.D.WithHerbimycinA treatment andwithout EGF stimulation. Inlays
inA–D show-pseudo color images of the pixel values (0–255) of the respective phospho-EGFR (Tyr 845) staining. E. Semi quantitativeﬂuorescence imaging (SQFI) values corresponding to
treatments presented in images A–D. Error bars= SEM, signiﬁcance with respect to EGF treated samples is calculated using a Student's t-test: p value b 0.05, signiﬁcant (*). Yellowmerge
in single cells (F, see white arrows) indicates activated states of EGFR, red ﬂuorescence (Tyr 845) internalized into early endosomes, green ﬂuorescence. (G, see white arrows) shows cul-
tures not treated with EGF with lack of yellow merge. Scale bar = 20 μm.
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granulated to very rough grains, thereby suggesting abundance of
transactivated EGFRs at different stages of activation.While ﬁne red ﬂuo-
rescence grains may indicate EGFR transactivation in a very early and/or
early stage, rough grains may point to clusters of transactivated recep-
tors, e.g. accumulated in endosomes (Fig. 1F/+EGF; G/−EGF), and there-
fore may represent later stages of EGFR transactivation, accompanying
receptor internalization. In fact, co-localization of activated receptors
with early endosomes in single cells could be proven by yellow merge
ﬂuorescence signals onto dual label of activated EGFR (red) and early
endosomal antigen 1 (EEA-1) (green) (Fig. 1F, with yellow merge indi-
cating early endosome-internalized activated EGFR, see white arrows).
3.2. EGF yields redistributive changes in localization levels of constituents
characterizing mature focal adhesions (FAs)
Integrin-based focal adhesions (FAs) are crucial for cells to sense,
transmit and adapt to biomechanical environmental cues like adhesionligand-spacing or substrate stiffness. Such sites of adhesion consist of a
plethora of intrinsic regulatory constituents, including α- and ß-
integrin subunits, FAK, Src, and zyxin, but also actin-inﬂuencing mole-
cules like p190RhoGAP, which can either bind to each other or can be
activated by one of the intrinsic partners, for example p190RhoGAP
via FAK or Src. Through this intrinsic network of molecular partners,
which can be subsumed under the term adhesome, cells are capable of
modulating structure and dynamics of these sites [9]. With respect to
the adhesome, receptor-occupied integrins are known to induce EGFR
phosphorylation at sites including the Src-typical tyrosine residue 845
[18,39]. Against the backgroundof such an adhesion receptor/growth fac-
tor receptor (GFR) cross-talk-mediatedGFR activation, the question arose
whether integrins and/or other adhesome network members can be
modulated by an activation of the EGFR. Against the background that
for the analyzed adhesome members, the focal adhesion integrin sub-
units ß1 (Fig. 2E, inlay) and ß3 (Fig. 3E, inlay) together with the FA mat-
uration marker zyxin (Fig. 4E, inlay), EGF yielded no obvious changes of
the total protein amount, as detected by western blotting, we employed
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in order to detect putative EGF-induced changes of localized levels.
In our experimental set-up corneal keratinocytes grown in the ab-
sence of EGF exhibited clear ß1 expressionwith emphasis at cell periph-
eral sites here coinciding with the apical green ﬂuorescent actin
cytoskeletal stretches (Fig. 2B). Basically, this situation also applied to
cells, cultured under EGF-supplemented conditions, though ß1 frequen-
cy of occurrence here appeared even more pronounced at the cell bor-
ders (Fig. 2A). For ß3 integrin, weak punctuate red ﬂuorescence with
cytoplasmic preference was seen in cultures devoid of EGF (Fig. 3B).
By marked contrast, EGF administration yielded signiﬁcant changes in
the frequency of occurrence of ß3-ﬂuorescence, which suggests an in
part EGF-mediated redistributive change in the localization level to
sites of actin tips at cell extensions and/or the cell periphery (Fig. 3A,
and see white arrows in inlay/heat map). For zyxin, measured differ-
ences in antigen frequency of occurrence between EGF-exposed cells
(Fig. 4A) and EGF-starved (Fig. 4B) were clearly exceeding the level of
signiﬁcance. While in both culture regimes late FA marker zyxinFig. 2. Integrin β1 staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for a
1.56 ng/ml EGF. B. Without EGF stimulation. C. With Herbimycin A (Herb) treatment and with
A–D show pseudo-color images of the pixel values (0–255) of the respective integrin β1 stain
presented in images A–D while E1 reveals equal protein expression detected by western blottin
using a Student's t-test: p value b 0.05, signiﬁcant (*). Scale bar = 20 μm.exclusively decorated cell peripheral extensions, as evidenced by co-
localized actin green ﬂuorescence in these regions, EGF led to a drastic
increase in zyxin frequency of occurrence (compare red ﬂuorescence
signal intensity in conjunction with corresponding pseudo-color-
based heat maps provided as inlay in Fig. 4A: +EGF with Fig. 4B:
−EGF). Although the regulatory mechanisms still have to be elucidated
in more detail, the data obtained from SQFI for the FA markers under
study strongly suggest EGF as one possible trigger for modulating
their localization levels in a way which in the cell behavior context
may favor FA constituent redistribution, thereby suggesting FA
reinforcement.
3.3. EGF modulates FAK and Src as EGFR- and integrin-receptor-proximal
events
Focal adhesion integrins including ß1 andß3 are knownactivators of
focal adhesion kinase FAK and thereby also Src-family kinases such as
Src (for review see [40]). Since we have detected clear frequency ofctin (green), DAPI counter stain for cell nucleus (blue). A. With 30 minute exposure to
EGF stimulation. D. With Herbimycin A treatment and without EGF stimulation. Inlays in
ing. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to treatments
g (WB). Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated
Fig. 3. Integrin β3 staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A. With 30 minute exposure to
1.56 ng/ml EGF. B. Without EGF stimulation. C. With Herbimycin A (Herb) treatment and with EGF stimulation. D. With Herbimycin A treatment and without EGF stimulation. Inlays in
A–D show pseudo-color images of the pixel values (0–255) of the respective integrin β3 staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to treatments
presented in images A — while E1 reveals equal protein expression detected by western blotting (WB). Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated
using a Student's t-test: p value b 0.05, signiﬁcant (*). Scale bar = 20 μm.
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subunits in response to EGF, we were next interested in investigating
if an EGF effect could also be noted for FAK and Src, respectively. To
this end, phosphorylated FAK at Tyr397, reﬂecting the autophosphory-
lation site mandatory for Src binding, was ﬁrst analyzed by SQFI follow-
ing EGF treatment.
To ensure that putative EGF modulation will only address activated
stages of FAK, Src as well as the MAP-kinases p42/44 and p190RhoGAP,
we initially checked the protein status per se by SQFI, in response to
1.56 ng/ml EGF. As exempliﬁed for FAK, Fig. 5 illustrates that frequency
of occurrence determined for red ﬂuorescence of total FAK, present in
the entire cytoplasm but also in regions of cell extensions was almost
equal irrespective of EGF (Fig. 5A: +EGF; B: −EGF). This indicates
that administration of the soluble growth factor did not affect the total
protein amount of FAK as integrin-proximal non-receptor tyrosine ki-
nase. While the FAK protein content obviously remained unchanged,
phosphorylation frequency of occurrence at Tyr397 clearly discrimi-
nates EGF-treated fromnon-treated cells. Though ﬂuorescence quantiﬁ-
cation revealed basal levels of phosphorylated Tyr397 in the non-treated situation (Fig. 6B), presumably mediated by FA-integrin ligand
occupancy, corneal keratinocytes exhibited large and signiﬁcant level
of increase in response to EGF (Fig. 6A). Of note, under both culture con-
ditions the Tyr397 signal was clearly detectable at cell margins, a posi-
tion closely coinciding with zyxin immunolocalization (compare
Section 3.2, zyxin, Fig. 4A and B with Fig. 6A and B, pFAK Tyr397), sug-
gesting that autophosphorylation of FAK occurred at FA sites. In this
context, it remains a subject of discussion whether higher levels detect-
ed for pFAK Tyr397 are a direct or indirect EGF effect, since increase in
Tyr397 phosphorylation coincided with reinforcement of FA constitu-
ents. Intriguingly, EGF yielded increased frequency of occurrence
of FAK phosphorylation not only at Tyr397, but also at Tyr576, as
demonstrated by detection of red ﬂuorescence pixels for the tyrosine
residue indicating that FAK acts as a kinase itself. Tyr576 phosphoryla-
tion was signiﬁcantly pronounced in cells exposed to EGF (Fig. 7A)
with matched untreated keratinocytes (Fig. 7B), already 30 min after
exposure. This rapid increase may point to involvement of Src rather
than a direct EGF effect, since Src has been shown to activate FAK kinase
activity [41].
Fig. 4. Zyxin staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A. With 30 minute exposure to 1.56 ng/ml
EGF. B. Without EGF stimulation. C. With Herbimycin A (Herb) treatment and with EGF stimulation. D. With Herbimycin A treatment and without EGF stimulation. Inlays in A–D show
pseudo-color images of the pixel values (0–255) of the respective zyxin staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to treatments presented in images
A–Dwhile E1 reveals equal protein expression detected bywestern blotting (WB). Error bars= SEM, signiﬁcancewith respect to EGF treated samples is calculated using a Student's t-test:
p value b 0.05, signiﬁcant (*). Scale bar = 20 μm.
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FAK autophosphorylation site Tyr397, we consequently were interested
in investigating the activation status of Src Tyr418 phosphorylation,Fig. 5. FAK staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green
ulation, C. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to treatments p
(0–255) of the respective FAK staining. Error bars = SEM, signiﬁcance with respect to EGF treasince autophosphorylation of FAK promotes Src binding and Tyr418
phosphorylation of Src indicates maximum Src activity. This maximum
activity is induced in the FAK–Src-complex through FAK kinase activity,), DAPI counter stain for cell nucleus (blue). A.With EGF stimulation, B.Without EGF stim-
resented in images A and B. Inlays in A and B show pseudo-color images of the pixel values
ted samples calculated using a Student's t-test: p value ≥ 0.05. Scale bar = 20 μm.
Fig. 6. Phospho-FAK (Tyr397) staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A.With 30minute exposure
to 1.56 ng/ml EGF. B.Without EGF stimulation. C.With Herbimycin A (Herb) treatment and with EGF stimulation. D.With Herbimycin A treatment and without EGF stimulation. Inlays in
A–D show pseudo-cooler images of the pixel values (0–255) of the respective phospho-FAK (Tyr397) staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to
treatments presented in images A–D. Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated using a Student's t-test: p value b 0.05, signiﬁcant (*). Scale bar =
20 μm.
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ylation [42]. In fact, SQFI proved massive and signiﬁcantly higher fre-
quency of occurrence of Tyr418 phosphorylation for Src when cells
were cultured in the presence of EGF (Fig. 8A) rather than the medium
lacking EGF (Fig. 8B). In EGF-stimulated cells the ﬂuorescence signal
preferentially decorated the cell borders, a localization which coincided
with that seen for FAK Tyr397 (compare therefore Fig. 6A with Fig. 8A).
This coincidence provides evidence for the presence of FAK–Src-com-
plexes at FA sites, and further suggests that EGF may promote putative
complex formation via increase in FAK Tyr397.
3.4. EGF reveals increase in MAP-kinase and p190RhoGAP activity as
receptor-distal events
Signaling cascades emerging from mechanotransducing FA-innate
integrin receptors as well as growth factor receptors (GFR) govern cell
behavior [20,43,44]. This signaling includes pathways and pathway-
immanent target molecules which direct cell behavioral aspects such
as proliferation, differentiation andmotility. Several routes of activation
have been described for MAP-kinases and p190RhoGAP in the contextof GFRs [20] and FAs [45,46]. Moreover, MAP-kinase signaling and
p190RhoGAP phosphorylation were also shown to emerge from Src
[47,48]. Against this background we now focused on MAP kinases
p42/44 (ERK 1/2) and the small GTPase RhoA antagonist p190RhoGAP,
known to be involved in the aforementioned behavioral features.
As detected by SQFI, EGF cell response was displayed by a signiﬁcant
higher frequency of occurrence of phosphorylated and thereby activat-
ed state of MAP-kinases p42/44 (Fig. 9A), while EGF-depleted counter-
parts showed only marginal MAP-kinase activity (Fig. 9B). Similar was
the situation seen for activated p190RhoGAP. As revealed by signiﬁ-
cance of antigen frequency of occurrence, EGF led to a clear increase in
phosphorylation at the Src-dependent site Tyr1105 (Fig. 10A), whereas
obvious lower levels of activation were detected in the absence of the
growth factor (Fig. 10B). Concerning the immunolocalization of activat-
ed p190RhoGAP, cells devoid of EGF displayed red ﬂuorescence in the
cytoplasm and in parts at the cell periphery, while EGF yielded much
stronger signals at both the cytoplasm but also the cell margins (com-
pare Fig. 10B with A). These ﬁndings identify MAP-kinases p42/44 and
p190RhoGAP as receptor-distal EGF-triggered events in our corneal
keratinocytes. In conjunction with the elevated levels seen for Src
Fig. 7. Phospho-FAK (Tyr 576) stainingof corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A.With 30minute exposure
to 1.56 ng/ml EGF. B.Without EGF stimulation. C.With Herbimycin A (Herb) treatment and with EGF stimulation. D.With Herbimycin A treatment and without EGF stimulation. Inlays in
A–D show pseudo-color images of the pixel values (0–255) of the respective phospho-FAK (Tyr576) staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding to
treatments presented in images A–D. Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated using a Student's t-test: p value b 0.05, signiﬁcant (*). Scale
bar = 20 μm.
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MAP-kinases and p190RhoGAP in response to EGF support the notion
that within a putative cross-talk between GFRs and FAs, including FAK
as a bridgingmolecule, Src may be the candidate key switch in the cau-
sation of the detected receptor-distal events.
An overview of the EGF-modulated frequency of occurrence of mol-
ecules and/or molecular events is depicted in Fig. 11A.
3.5. Src-speciﬁc inhibitor Herbimycin A abrogates EGF response except
Tyr397-phophorylated FAK
Under the given culture regime, i.e.maintaining corneal keratinocytes
in the presence or absence of EGF, we observed enhancement of FA con-
stituent redistribution to the cell periphery concomitant with increased
levels of activated Src, FAK, MAP-kinases and p190RhoGAP, respectively.
Since FAK-bound Src has been described as a pivotal molecule in the
integrin GFR-interplay, we applied Herbimycin A (Herb), a well-known
Src-kinase inhibitor, to analyze whether the EGF-triggered elevation re-
sponse in our study is Src-dependent or not. In the context of the inhibi-
tor experiments it is noteworthy that for activated states of Src, MAP-kinases p42/44 and p190RhoGAP in addition to SQFI western blotting
(WB)were carried out to prove reliability of the quantifying ﬂuorescence
imaging approach.
As illustrated in Fig. 8, application of the inhibitor led to the antici-
pated drastic down-modulation of Tyr418-phosphorylated Src, proving
that it signiﬁcantly reduces the maximum kinase activity of Src. This
ﬁnding was independent of the presence (Fig. 8C) or absence (Fig. 8D)
of EGF, though cells exhibited an obvious residual activity. This situa-
tion, determined by SQFI was corroborated through WB, by probing of
the membranes with the same antibody used for ﬂuorescence imaging.
Accordingly, the Herbimycin A-treated versus non-treated cells re-
vealed the existence of signiﬁcant differences in Src activation (Fig. 8F,
G). Of note, in the case ofWB-detection, probing of the respectivemem-
braneswith GAPDH and the antibodies at a time detecting the total pro-
tein of Src, p42/44 and p190RhoGAP (Figs. 8F, 9F, 10F) yielded equal
band intensities of protein, thereby proving that neither EGF adminis-
tration nor the inhibitor in the applied concentration of 1 μg had an im-
pact on the total protein amount of the tested biomarkers (Fig. 8F, 9F,
10F). With respect to FAK an unexpected ﬁnding was the status of
Tyr397 phosphorylation in the presence of Herbimycin A in EGF-
Fig. 8. Phospho-Src (Tyr418) staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A.With 30minute exposure
to 1.56 ng/ml EGF. B. Without EGF stimulation. C. With Herbimycin A (Herb) treatment and with EGF stimulation. D. With Herbimycin A treatment and without EGF stimulation. Inlays
in A–D show pseudo-color images of the pixel values (0–255) of the respective phospho-Src (Tyr418) staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values corresponding
to treatments presented in images A–D. Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated using a Student's t-test: p value b 0.05, signiﬁcant (*). F. Western
blot showing relative intensity of phospho-Src (Tyr418) according to treatment and in comparison to GAPDH and Src total protein controls. G. Western blot densitometric volume (AU)
(intensity × area = arbitrary units) for phospho-Src (Tyr418) displaying Student's t-test calculated signiﬁcance with respect to EGF treated cells. Error bars show SEM; p value b 0.05,
signiﬁcant (*). Scale bar = 20 μm.
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alone (compare Fig. 6A, E with C, E), and was much more pronounced
than in inhibitor-treated cells devoid of EGF (Fig. 6D). In comparison
to EGF application (Fig. 7A), FAK Tyr576 phosphorylation appeared
clearly down-modulated in the presence of the inhibitor, regardless of
EGF supplementation (compare Fig. 7C, D). This FAK-inherent diver-
gence suggests that Herbimycin A may indirectly act on FAK through
down-modulation of Src activity, since Src phosphorylates FAK at
Y576. The unexpected ﬁnding that Herbimycin A did not abrogate
Tyr397 phosphorylation supports the notion that persistence of
Tyr397 does not directly require Src and may be a Src-independent
and/or secondary effect. For the receptor-distal events MAP-kinases
p42/44 (Fig. 9) and RhoA antagonist p190RhoGAP (Fig. 10), an EGF-
independent marked down-regulation of phosphorylation was seen in
the presence of the inhibitor. With matched EGF-stimulated cells (de-
scribed in Section 3.4), for p42/44 (Fig. 9B) and p190RhoGAP
(Fig. 10B), detected phosphorylation almost diminished in inhibitor-
exposed cells (Fig. 9C, D for p42/44; Fig. 10C, D for p190RhoGAP). In
both cases, the SQFI results were conﬁrmed by WB, proving signiﬁcant
decrease of phosphorylation in inhibitor-exposed corneal keratinocytes
even in the presence of EGF (Fig. 9F, G for p42/44 and Fig. 10F, G for
p190RhoGAP). These ﬁndings support the notion of a Src-dependent ef-
fect which applies for both cases of receptor-distal events under study.
While p190RhoGAP and MAP-kinases p42/44 as receptor-distal as
well as FAK and Src as receptor-proximal events exhibited clear suscep-
tibility to the Src inhibitor Herbimycin A, wewere next interested in ex-
ploring whether the phosphorylated EGFR and the integrin receptors
together with zyxin were affected by inhibitor treatment. With respect
to the EGFR, inhibitor response indicated marked and signiﬁcant de-
crease in the frequency of occurrence of Tyr845 phosphorylation
(Fig. 1C) which was even more prominent in the+inhibitor/−EGF sit-
uation (Fig. 1D). Despite the observed decrease, the remnants of Tyr845phosphorylation in cells exposed to the inhibitor plus EGF (Fig. 1C),may
reﬂect a residual Tyr845 transphosphorylation through Src, which also
exhibits remaining activity in the presence of Herbimycin A (compare
Fig. 1C with Fig. 8C), Section 3.5 above. For the integrin ECM-receptors
ß1 and ß3 but also for zyxin as further FA constituent, SQFI determined
clear abrogation (Figs. 2C, E for ß1; 3C, E for ß3, and 4C, E for zyxin) of
the EGF-associated elevation of redistribution (Figs. 2A, E for ß1; 3A, E
for ß3, and 4A, E for zyxin), described in Section 3.2, as inhibitor cell re-
sponse. Despite this abrogation, a basal presence at adhesion sites could
be denoted for all three FA constituents in the inhibitor situation, re-
gardless from presence (Figs. 2C for ß1; 3C for ß3, and 4C for zyxin) or
absence (Figs. 2D for ß1; 3D for ß3, and 4D for zyxin) of EGF. This
basal presencemay reﬂect the steady state level of integrin and zyxin lo-
calization at FAs due to adhesion of the cells to their culture substratum.
The Herbimycin A-associated abrogation of the EGF-mediated ef-
fects under study is summarized in Fig. 11B.
4. Discussion
Within the interactions described between growth factor receptors
(GFRs) and integrins as extracellular matrix (ECM) receptors, the recip-
rocal cross-talk appears as amutual collaboration, in which for example
adhesion can trigger ligand-independent activation and growth factors
can induce adhesionmolecules to propagate adhesion-independent sig-
nals [19]. Among themolecules, which facilitate this cross-talk, FAK has
been identiﬁed as an important receptor-proximal link between growth
factor receptor and integrin signaling pathways [23], while Src has been
proven an essential co-operator between integrin and growth factor sig-
naling [17]. In the present study, we showed that even in the presence
of activity in both receptor systems, short-term administration of EGF
led to reinforcement in the frequency of occurrence of FA constituents
at adhesion sites, concomitant with involvement of MAP-kinases and
Fig. 9. Phospho-p44/42 (Erk1/2) (Thr202/Tyr204) staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A.With
30 minute exposure to 1.56 ng/ml EGF. B. Without EGF stimulation. C. With Herbimycin A (Herb) treatment and with EGF stimulation. D. With Herbimycin A treatment and
without EGF stimulation. Inlays in A–D show pseudo-color images of the pixel values (0–255) of the respective phospho-p44/42 (Thr202/Tyr204) staining. E. Semi quantitative
ﬂuorescence imaging (SQFI) values corresponding to treatments presented in images A–D. Error bars = SEM, signiﬁcance with respect to EGF treated samples is calculated using a
Student's t-test: p value b 0.05, signiﬁcant (*). F. Western blot showing relative intensity of phospho-p44/42 (Erk1/2) (Thr202/Tyr204) according to treatment and in comparison to
GAPDH and p42/44 total protein controls. G. Western blot densitometric volume (AU) (intensity × area = arbitrary units) for phospho-p44/42 (Thr202/Tyr204) displaying Student's t-
test calculated signiﬁcance with respect to EGF treated cells. Error bars show SEM; p value b 0.05, signiﬁcant (*). Scale bar = 20 μm.
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proximal events. With the inclusion of the Src-speciﬁc inhibitor
Herbimycin A, our consecutively discussed data from the mechanistic
viewpoint support a hypothetical cybernetic model, in which Src ap-
pears to be an important molecule in mediating the EGF-triggered ef-
fects (Fig. 12). Further, our ﬁndings suggest that the observed EGF
response underlies a putative GFR integrin cross-talk.
Regarding Src, EGF led to a clear gain in Tyr418 phosphorylation,
which in the corneal keratinocyte points to an acquirement of maxi-
mum kinase activity, since Src phosphorylation at this tyrosine residue
was reported as a requirement to accomplish maximum activity [42].
One way to achieve this maximum Src activity, described by Wu and
co-workers, involves FAK acting as a kinase itself, a feature that ema-
nates from the FAK kinase domain [42]. Active Src kinase promotes
Tyr576/577 phosphorylation of FAK, the latter representing the FAK ki-
nase activity (for review, see [41,49–51]) (Fig. 12, curl 3). In this regard,
the ﬁnding that elevated levels of FAK Tyr576 phosphorylation could be
noted as an EGF response in our cells supports the notion that increased
Tyr576 phosphorylation contributes to Src Tyr418 phosphorylation
(Fig. 12, curl 4). This in turn maintains Tyr576 phosphorylation and
thus FAK kinase activity (Fig. 12, curl 4). Proof of concept of this notion
is provided by Herbimycin A application,which led to a drastic decrease
in Tyr418 phosphorylation-mediated Src activity but also to decreased
FAK Tyr576 phosphorylation.
Concomitant with increased Src activation, we detected signiﬁcant
up-regulation of Y845 phosphorylation of EGFR, which has been de-
scribed to be unnecessary for ligand-induced EGFR activation [5].
Though dispensable for ligand-induced activation, Tyr845 has been
proven to be the primary site for receptor transactivation via Src [17,
18,20]. Against this background, the enhanced EGFR activity detected
after EGF treatment in the corneal cells appears likely to represent aSrc-mediated transphosphorylation and/or transactivation (Fig. 12,
curl 5). Moreover, the EGF-mediated EGFR Tyr845 phosphorylation in
our cells suggests the existence of a physical interaction between the re-
ceptor and Src. Such physical interaction is substantiated by complexes,
whose formation is facilitated by the EGF-ligand binding-induced EGFR-
inherent autophosphorylation of Tyr residues. These phosphotyrosines
serve as docking sites for a variety of signaling molecules like Src that
comprise a phosphotyrosine-binding sequence [32]. In this context it
appears noteworthy that with respect to Herbimycin A it could be
shown that the Src-speciﬁc inhibitor does not abrogate formation of
Src-EGFR complexes [52]. Further, it does not interfere with EGFR
transphosphorylation and does not inhibit its tyrosine kinase activity
per se [52–54]. Due to this lack of interference, the down-modulation
of EGFR transphosphorylation and/or activation we saw can be consid-
ered a veritable effect of Herbimycin A-speciﬁc Src kinase inhibition.
Based on our further observation that Herbimycin A did not abrogate
Tyr397 phosphorylation of FAK it can be speculated that Tyr397 of
FAK is a direct EFG target (Fig. 12, curl 1), as suggested by analogous
studies on ﬁbroblasts, which exhibited stimulation of Tyr397 phosphor-
ylation in response to endothelin, an endothelium-derived peptide
hormone consortium [55]. Further, previous studies on FAK-EGFR inter-
action have shown that the binding of the FAK-N-terminal region to the
EGFR appears to be sufﬁcient to induce strong EGF-mediated FAK phos-
phorylation at Tyr397 [23]. Regarding the EGF/ Herbimycin A-situation-
associated even more pronounced FAK phosphorylation at Tyr397, a
closed loop of FAK autophosphorylation resulting in phosphotyrosine
397 accumulationmay be due to slowing-downof FAs turn over, the lat-
ter evolving from the Herbimycin A-induced Src inhibition. Due to this
persistence of high FAK Tyr397 phosphorylation it is plausible that the
residual EGFR transphosphorylation, seen in the presence of the inhibi-
tor, may be a consequence of Src base activity. This base activity can
Fig. 10. Phospho-RhoGAP (Tyr 1105) staining of corneal keratinocytes (red), Phalloidin-Alexa488 staining for actin (green), DAPI counter stain for cell nucleus (blue). A. With 30minute
exposure to 1.56 ng/ml EGF. B.Without EGF stimulation. C.With Herbimycin A (Herb) treatment andwith EGF stimulation. D.With Herbimycin A treatment andwithout EGF stimulation.
Inlays in A–D show pseudo-color images of the pixel values (0–255) of the respective phospho-RhoGAP (Tyr1105) staining. E. Semi quantitative ﬂuorescence imaging (SQFI) values
corresponding to treatments presented in images A–D. Error bars= SEM, signiﬁcance with respect to EGF treated samples is calculated using a Student's t-test: p value b 0.05, signiﬁcant
(*). F. Western blot showing relative intensity of phospho-RhoGAP (Tyr1105) according to treatment and in comparison to GAPDH and RhoGAP total protein controls. G. Western blot
densitometric volume (AU) (intensity x area = arbitrary units) for phospho-RhoGAP (Tyr418) displaying Student's t-test calculated signiﬁcance with respect to EGF treated cells. Error
bars show SEM; p value b 0.05, signiﬁcant (*). Scale bar = 20 μm.
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the FAK–Src-complex, the latter governed by Tyr397 of FAK as a target
region for Src docking ([56], for review, see [51]) (Fig. 12, curl 2). How-
ever, such a residual EGFR transphosphorylation appears to be unable to
maintain the EGF-associated increase in p42/44 MAP-kinase activity,
seen in the present study. In the light of the fact that Herbimycin A
does not hamper EGFR tyrosine kinase activity in general, Src-induced
Tyr845 EGFR transphosphorylation increasingly becomes one possible
causative for the seen MAP-kinase activity increase in our corneal
keratinocytes (Fig. 12, curl 7). This assumption is backed up by anFig. 11.Modulation of focal adhesion constituents, EGF-receptor and integrin-proximal and dis
gation of EGF-mediated effects.EGFR-review published by Sato, which describes activation of MAP-
kinase family members as one cellular function regulated by phosphor-
ylation of EGFR on Tyr845 [20]. On the other hand, a direct activation
interrelationship between the MAP-kinases and Src appears also possi-
ble since it has been reported that v-Src in addition to PI-3 K activates
the MAP-kinase cascade [47] (Fig. 12, curl 6). Moreover, our ﬁndings
using the Src-speciﬁc inhibitor Herbimycin A, which led to a down-
modulation of MAP-kinase activity, are in line with previous reports
employing PP-1 as Src kinase inhibitor, thereby observing also MAP-
kinase activity inhibition [57]. Though in both cases, the EGF-tal events in response to EGF, A. EGF-stimulated effects. B. Herbimycin A-associated abro-
Fig. 12. Hypothetical cybernetic model of the EGF stimulatory effects observed in corneal cells comprising “Src” as the key molecule: (1) EGF induces increase in Tyr397 FAK phosphor-
ylation via binding of the FAK-N-terminal region to the EGFR. (2) Tyr397 phosphorylated FAK undergoes complex formation with Src which in turn develops base activity through con-
formational changes. (3) Src basal activity phosphorylates FAK at Tyr576, thereby inducing FAK kinase activity. (4) FAK kinase activity leads to progressive Tyr418 Src phosphorylation,
thereby promoting Src to unfold maximum activity. (5) Maximally activated Src transphosphorylates and/or transactivates EGFR. (6) Src directly activates MAP-kinases ERK1/2/p42/
44. (7) Src indirectly activates ERK1/2/ p42/44 trough EGFR transactivation. (8) Src directly phosphorylates p190RhoGAP at Tyr1105, thereby leading to its activation. (9) Src indirectly
promotes p190RhoGAP activation trough EGFR transactivation. (10)MaximumSrc activity directly stimulates increase of FA constituents' expression. (11)MaximumSrc activity indirectly
stimulates increase of FA constituents' expression via transactivation of EGFR. (12) In addition to Src, FAK promotes reinforcement of FA constituents' expression.
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transphosphorylation detection revealed an in part grainy ﬂuorescence
pattern, possibly indicating endosomal receptor stages [11], the status
of activity of the receptor can be different. While transphosphorylated
receptor retains its signaling action in endosomes as well [58],
Herbimycin A has been shown to support receptor ubiquitination and
degradation [59]. Hence, ubiquitinated receptors are excluded from fur-
ther action [11,20].
With respect to the adhesion partners in the presumptive GFR-
integrin-cross-talk, namely integrins ß1 and ß3 as well as zyxin, we
have detected constant total protein amounts. Irrespective from con-
stant protein levels, the analyzed constituents of FAs, displayed clear
frequency of occurrence changes with preference to adhesion sites.
These changes of localized levels indicate their redistribution to sites
of adhesion, thereby pointing to reinforcement of focal adhesions. For
all three constituents, we could observe that antigen-speciﬁc red ﬂuo-
rescence signals were preferentially seen at the cell periphery, here
mainly co-localizing with the actin tips, as indicated by the actin green
ﬂuorescence. This co-localization strongly suggests the presence of ma-
ture FAs, since zyxin is a veriﬁed biomarker for late stage FAs [5,7]. This
notion is supported by the immunolocalization of Tyr418 phosphorylat-
ed Src in the corneal cells, which is likewise visible at cell peripheral
sites. Such peripheral Src abundance in conjunction with coinciding lo-
calization of FA constituents under study can be an indication not only
for the existence of the aforementioned EGFR–Src complexes [52], but
also for a Src link to FAs, including FAK and/or the FAK–Src complex
(Fig. 12, curl 2) in the form of a bridge. Support for Src being involved
in this bridge and facilitating GFR-integrin-cross talk is obtained from
studies on ß3 integrin. In these studies, ß3 could be shown to promote
Src activation via direct interactions between Src and ß3 cytoplasmic
tails [60]. A possible explanation for the detected changes of localized
levels of FA constituents to sites of adhesion in response to EGF is that
the EGF-triggered increase in FAK Tyr397 phosphorylation, seen in our
cells, may exert a stimulating effect on ß1 and/or ß3 integrin and
possibly also zyxin expression (Fig. 12, curl 12). This assumption is
based on in vitro studies in ﬁbroblasts, which show that the FAKautophosphorylation site Tyr397 is required for integrin activation and
integrin-mediated enhancement of adhesion strengthening during the
creation of cell-extracellular environment-directed forces [61]. Another
study performed in human cervical adenocarcinoma cells reported an
EGF-mediated increase in α2ß1 integrin, the latter accompanied by a
decrease in FAK phosphorylation [62]. Although this study supports
the hypothesis of a direct EGF effect on integrin expression, a possible
interrelationship between FAKphosphorylation and integrin expression
cannot be excluded. Moreover, such an interrelationship is not inevita-
bly bound to lower levels of FAK phosphorylation, as reported by
Yamanaka et al., since he and his group have only detected general
FAK phosphorylation instead of a Tyr residue-speciﬁc form. Hence, in-
creased Tyr397 phosphorylation, as seen by us, may not be obligatory
in order to indicate higher levels of total FAK phosphorylation, since in-
creased Tyr397 levels can be negatively overcompensated by a respec-
tive decrease in Tyr576/577 phosphorylation. A further explanation
for the higher frequencies of occurrence of FA constituent at adhesion
sites is recruited from the Herbimycin A experiment, which moves the
focus to Src (Fig. 12, curl 10). This focus on Src arises from the decrease
in FA constituent frequency of occurrence at the cell periphery in our
cells, concomitantly detected with the inhibitor-directed diminishment
of Src Tyr418 phosphorylation. Independent from the previously
discussed FAK Tyr397 notion, a direct EGF effect as suggested by
Yamanaka and co-workers with the inclusion of a Src-mediated EGFR
transactivation may also become plausible for the observed integrin lo-
calization changeswith preference to FAs (Fig. 12, curl 11). Such a direct
EGF effect, including the Src-triggered EGFR transactivation may also
hold true for zyxin (Fig. 12, curl 11), sincewe have also seen signiﬁcant-
ly lower levels of this FA constituent at FA sites in the presence of
Herbimycin A. On the other hand, the detected higher cell peripheral
zyxin frequency of occurrence as an EGF response may be a result of
changes in actin turn over-associated actin nucleation, which has been
reported by Chan and co-workers to be stimulus-responsive to EGF.
Such an EGF-induced increase in actin nucleation, which was described
for the leading edge of cells [63], generally coincides with sites of
forming and maturing FAs, therefore implying increased rates of zyxin.
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transient cell response to EGF included a cycle of adhesion strengthen-
ing followed by weakening, which was responsible for a temporally de-
layed retraction. Causally, this retraction delay was going along with
paxillin recruitment to FAs, which in addition to rapid FA assembly
yielded FA growth. A detailed analysis of paxillin phosphorylation pro-
vided evidence that EGF-induced FA maturation precedes retraction-
required FA disassembly [64]. Based on these data it cannot be ruled
out that EGF-triggered FA-maturation response, in addition to paxillin
recruitment, includes thematurationmarker zyxin, as seen by us, there-
by transiently emphasizing maturation and thus strengthening/ rein-
forcement of FAs before motility processes like retraction are induced.
With respect to our study this notion is in principal in linewith theﬁnd-
ings of Schneider and co-workers, since in addition to the redistribution
of FA constituents to adhesion sites,we have found an EGF-mediated in-
crease in p190RhoGAP activation, substantiating an important trigger to
cell motility-including retraction. A second interesting aspect regarding
the Schneider study is that the EGF effects occur rapid and transient. Al-
though not strictly matching with the time scale performed by
Schneider and his group, this rapidity and transience is in accordance
with our own data on EGF (Supplementary Figs. 1–3), which revealed
a clear redistribution to FA sites for zyxin (Supplementary Fig. 3), ß1
(Supplementary Fig. 1), and ß3 (Supplementary Fig. 2) as well after
30 min, which declines after 60 min and 180 min post stimulation.
Regarding the receptor distal events under study, p190RhoGAP
serves as an antagonist of the actin stress ﬁber-regulating small GTPase
RhoA [65], therebymaking p190RhoGAP an important molecule for the
regulation of cell motility [46]. As reported by several groups,
p190RhoGAP is a direct Src target and activated by Src through Tyr
phosphorylation [27,46], particularly at Tyr1105 [48] (Fig. 12, curl 8).
This Y1105 phosphorylation is required for complex formation between
p190RhoGAP and p120RasGAP, thereby preventing p190RhoGAP inac-
tivation due to dephosphorylation [66]. Alternatively, p190RhoGAP
can be phosphorylated at Tyr1087 to achieve complex formation with
p120RasGAP, and it has been reported that FAK activity in a complex
comprising p120RasGAP/p190RhoGAP and FAK is capable to support
subsequent Y phosphorylation of p190RhoGAP [46]. In addition to this
FAK involvement in p190RhoGAP activation, Balanis and his group
have provided evidence for EGFR participation in p190RhoGAP activa-
tion (Fig. 12, curl 9). Here, a receptor cross talk axis formed by ß3
integrin and activated EGFR under inclusion of p120RasGAP as physical
linker between EGFR and p190RhoGAP is primarily responsible for
p190RhoGAP activation [5,27]. Consequently, the EGF-associated
p190RhoGAP increase seen in our corneal cells is likely to be mediated
by activated Src (Fig. 12, curl 8), since we have used an antibody specif-
ically recognizing the previously mentioned Src phosphorylation site of
p190RhoGAP at Tyr1105. Proving Src and no other kinases like Arg pro-
tein kinases (RTKs) (Abl gene-related kinases) [67] the key player for
p190RhoGAP activation unto EGF application in the employed cell sys-
tem is substantiated by the Herbimycin A administration, which clearly
abrogates the p190RhoGAP-EGF-response to a level below the non-EGF
situation.Moreover, ourﬁndings support the notion that in case of EGFR
participation, involvement of Src-transactivated EGFR appears favorable
in increased p190RhoGAP activation (Fig. 12, curl 9) rather than
autophosphorylated EGFR, since Herbimycin A does not hamper
EGFR activation per se. From SQFI measurements, phosphorylated
p190RhoGAP revealed increased activity in response to EGF but was
also present in the absence of the growth factor, thereby indicating an
adhesion induced base activity, which may be mediated by various ki-
nases including Src, FAK, the aforementioned Arg PTKs, and/or activated
EGFR. Mechanistically, FAK kinase activity and/or EGFR transactivation
via Src also cannot be considered as a possible source of p190RhoGAP
phosphorylation since Herbimycin A treatment obviously prevents Src
from phosphorylating FAK at Tyr576 and/or transphosphorylation of
EGFR at Tyr845, as seen by us through respective ﬂuorescence intensity
diminishment.While in both of the cases described above other than Srcphosphorylation, p190RhoGAP is recruited to the cell periphery, our
p190RhoGAP ﬂuorescence pattern revealed cytoplasmic as well as pe-
ripheral protein distribution. Based on the FAK and EGFR models for
p190RhoGAP activation, which employ p120RasGAP as a complex part-
ner, the ﬂuorescence pattern detected for p190RhoGAP in our cells sug-
gests the abundance of directly phosphorylated p190RhoGAP protein,
which has been in parts re-distributed to cell peripheral sites. Here, at
this location it is now available to form the degradation-protecting com-
plexes with p120RasGAP at the putative receptor cross-talk bridge,
consisting of ß3 integrin and EGFR and/or FAK/Src-complexes, respec-
tively. Therefore, our p190RhoGAP pattern may indicate a very early
or preparatory stage of affording the corneal keratinocytes the capacity
for motility.5. Conclusions
In summary, cell treatmentwith EGF triggered a clear modulation in
the frequency of occurrence indicating changes in localized levels, i.e.
redistribution, and/or activation of molecules, which participate in the
constitution of mature FAs, but also in GFR and adhesion receptor prox-
imal and distal signaling events. By administration of the Src kinase-
speciﬁc inhibitor Herbimycin A, the EGF response was completely
abolished, except for Tyr397 phosphorylation of FAK. Though MAP-
kinase and p190RhoGAP signaling can be modulated by mechanisms
other than Src, our results suggest that Src plays a key role in the ob-
served stimulatory effects in the corneal cells (Fig. 12). As outlined in
Fig. 11A, our ﬁndings support the notion that EGF affects cell behavior
in a dual fashion. On the one hand, EGF yielded a clear redistribution
of constituents of mature FAs at FA-typical sites, which points to FA re-
inforcement while on the other hand it elevated activation of RhoA an-
tagonist p190RhoGAP, decisive for cell motility. Further, the ﬁndings
provide evidence that the EGF response underlies a GFR-integrin
cross-talk. Understanding the intricacy of the signaling processes ema-
nating from GFRs and integrins and their cross-talk-related receptor-
proximal as well as -distal events will help to deepen the knowledge
of themechanisms underlying cell behavioral features such as adhesion
and/or motility. With emphasis on Src, the knowledge gain obtained
from this study,will help to identify additional keymoleculesmechanis-
tically involved in cell behavior regulation.
Supplementary data to this article can be found online at http://dx.
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